Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Protective Effect of Oral BCG and Inactivated Mycobacterium bovis Vaccines in European Badgers (Meles meles) Experimentally Infected With M. bovis

  • Balseiro Morales, Ana María
  • Prieto, José Miguel
  • Álvarez, Vega
  • Lesellier, Sandrine
  • Dave, Dipesh
  • Salguero, Francisco Javier
  • Sevilla, Iker A.
  • Infantes-Lorenzo, José Antonio
  • Garrido, Joseba M.
  • Adriaensen, Hans
  • Juste, Ramón A.
  • Barral, Marta
[EN] In Europe, badgers (Meles meles) are recognized as major tuberculosis (TB) reservoir hosts with the potential to transmit infection to associated cattle herds. Recent studies in Spain have demonstrated that vaccination with a heat-inactivated Mycobacterium bovis vaccine (HIMB) successfully protects captive wild boar and red deer against progressive disease. The aim of this study was to evaluate the efficacy of two oral vaccines against TB in a badger model: the live-attenuated M. bovis bacillus Calmette-Guérin BCG vaccine (Danish strain) and a HIMB vaccine. Twenty-four badgers were separated in three treatment groups: oral vaccinated with live BCG (108 CFU, n = 5), oral vaccinated with HIMB (107 CFU, n = 7), and unvaccinated controls (n = 12). All badgers were experimentally infected with M. bovis (103 CFU) by the endobronchial route targeting the right middle lung lobe. Throughout the study, clinical, immunological, pathological, and bacteriological parameters of infection were measured. Both vaccines conferred protection against experimental TB in badger, as measured by a reduction of the severity and lesion volumes. Based on these data, HIMB vaccination appears to be a promising TB oral vaccine candidate for badgers in endemic countries., SI, This study was funded by a grant from Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), reference number RTA2014-00002-C02 (FEDER co-funded), the Principado de Asturias, PCTI 2018–2020 (GRUPIN: IDI2018-000237 and FEDER), and Departamento de Desarrollo Económico e Infraestructuras del Gobierno Vasco. This study was also funded by Ministerio de Ciencia, Innovación y Universidades (MCIU), the Agencia Estatal de Investigación (AEI) reference project RTI2018-096010-B-C21 and Fondo Europeo de Desarrollo Regional (FEDER). DEFRA also funded APHA staff for their participation in the study and for the purchase of BCG from Statens Serum Institute (Copenhagen, Denmark)., Authors thank Cristina Blanco Vázquez, Miriam Martínez de Egidua, Xeider Gerrikagoitia, Valentin Wacheux, Amaia Etxezarreta, Olalla Torrontegui, Si Palmer, Bernat Pérez de Val, and Enric Vidal for their collaboration during the processing of samples, Gareth Williams for providing BCG and Colin Birch for helping in calculating the disease burden scores. Authors also thank Kevin P. Dalton for critically reviewing the manuscript.
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

New serological platform for detecting antibodies against Mycobacterium tuberculosis complex in European badgers

  • Infantes Lorenzo, José A.
  • Dave, Dipesh
  • Moreno, Inmaculada
  • Anderson, Paul
  • Lesellier, Sandrine
  • Gormley, Eamonn
  • Domínguez, Lucas
  • Balseiro Morales, Ana María
  • Cortázar, Christian
  • Domínguez, Mercedes
  • Salguero, Francisco Javier
[EN]European badgers (Meles meles) have been identified as wildlife reservoirs for Mycobacterium bovis in the UK and Ireland, and may also have a role in the epidemiology of animal tuberculosis in other European regions. Thus, detection of M. bovis-infected badgers may be required for the purposes of surveillance and monitoring of disease levels in infected populations. Current serological assays to detect M. bovis infection in live badgers, while rapid and inexpensive, show limited diagnostic sensitivity. Here we describe and evaluate new ELISA platforms for the recognition of the P22 multiprotein complex derived from the purified protein derivative (PPD) of M. bovis. The recognition of IgG against P22 multiprotein complex derived from PPD-B was tested by ELISA in the serum of badgers from the UK, Ireland and Spain. TB infection in the badgers was indicated by the presence of M. bovis in tissues by culture and histology at post-mortem examination and TB-free status was established by repeated negativity in the interferon c release assay (IGRA). In experimentally infected badgers, humoral antibody responses against P22 developed within 45 days post-infection. The ELISA tests showed estimated sensitivity levels of 74–82% in experimentally and naturally infected badgers with specifici-ties ranging from 75% to 100% depending on the badger population tested. The P22 multi-antigen based ELI-SAs provide a sensitive and specific test platform for improved tuberculosis surveillance in badgers., SI, This work was supported by the Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria of Spain (INIA; RTA2015-00043-C02-02) and the TAVS-CM Programme of the Comunidad de Madrid (S2013/ABI-2747), cofinanced by the FEDER fund ‘A way to build Europe’. This work was partially supported by a FEDER co-funded grant from INIA (RTA2014-00002-C02-01). Jose Antonio Infantes-Lorenzo was supported by an FPU contract-fellowship (Formación de Profesorado Universitario) from the Ministerio de Educación, Cultura y Deporte of the Spanish Government (FPU2013/6000).
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Assessment of BCG and inactivated Mycobacterium bovis vaccines in an experimental tuberculosis infection model in sheep

  • Balseiro Morales, Ana María
  • Altuzarra, Raúl
  • Vidal, Enric
  • Moll, Xavier
  • Espada, Yvonne
  • Sevilla, Iker A.
  • Domingo, Mariano
  • Garrido, Joseba M.
  • Juste, Ramón A.
  • Prieto, Miguel
  • Pérez de Val, Bernat
[EN]Background/Aims: Animal tuberculosis (TB) is a complex animal health problem that causes disruption to trade and significant economic losses. TB involves a multi-host system where sheep, traditionally considered a rare host of this infection, have been recently included. The aims of this study were to develop an experimental TB infection model in sheep with a Mycobacterium caprae field strain isolated from a tuberculous diseased ewe, and to use this to evaluate the safety and efficacy of two vaccines against TB in sheep, the live-attenuated M. bovis BCG vaccine (Danish strain) and a heat-inactivated M. bovis (HIMB) vaccine. Methods: Eighteen 2 month-old lambs were experimentally challenged with M. caprae by the endotracheal route (1.5 × 103 CFU). They were separated per treatment group into parenterally vaccinated with a live BCG Danish strain vaccine (n = 6), orally vaccinated with a suspension of HIMB (n = 6) and unvaccinated controls (n = 6). Clinical, immunological, pathological and bacteriological parameters of infection were measured. Results: All lambs were successfully infected and developed gross TB lesions in the respiratory system. The BCG vaccine conferred considerable protection against experimental TB in lambs, as measured by a reduction of the gross lesion volumes and bacterial load. However, HIMB vaccinated animals did not show protection. Conclusions: This study proposes a reliable new experimental model for a better understanding of tuberculosis in sheep. BCG vaccination offers an effective prospect for controlling the disease. Moreover alternative doses and/or routes of administration should be considered to evaluate the efficacy of the HIMB vaccine candidate., SI, We are grateful to Albert Canturri (UAB), Maite Martín, Zoraida Cervera and the staff of the BSL-3 Unit of IRTA-CReSA for their technical support. We also thank Kevin P. Dalton for critically reviewing the manuscript. IRTA is supported by CERCA Programme / Generalitat de Catalunya.